Smoking-induced vascular disease: a new twist on an old theme.
McNamara
P
P
FitzGerald
G A
GA
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism; D051792:Basic Helix-Loop-Helix Proteins; D002986:Clinical Trials as Topic; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004198:Disease Susceptibility; D015777:Eicosanoids / Q000378:metabolism; D018257:Helix-Loop-Helix Motifs; D006801:Humans; D009419:Nerve Tissue Proteins / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D011084:Polycyclic Aromatic Hydrocarbons / Q000009:adverse effects; D011453:Prostaglandins / Q000378:metabolism; D017434:Protein Structure, Tertiary; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism; D012907:Smoking / Q000009:adverse effects*; D014157:Transcription Factors / Q000378:metabolism; D014652:Vascular Diseases / Q000209:etiology* / Q000378:metabolism
D000975:Antioxidants; D051792:Basic Helix-Loop-Helix Proteins; D003577:Cytochrome P-450 Enzyme System; D015777:Eicosanoids; D009419:Nerve Tissue Proteins; D011084:Polycyclic Aromatic Hydrocarbons; D011453:Prostaglandins; D018336:Receptors, Aryl Hydrocarbon; D014157:Transcription Factors; C104264:NPAS2 protein, human